Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

A tumor suppressive DNA translocase named FANCM.

Basbous J, Constantinou A.

Crit Rev Biochem Mol Biol. 2019 Feb;54(1):27-40. doi: 10.1080/10409238.2019.1568963. Epub 2019 Feb 4.

PMID:
30714416
2.

Recruitment of ubiquitin-activating enzyme UBA1 to DNA by poly(ADP-ribose) promotes ATR signalling.

Kumbhar R, Vidal-Eychenié S, Kontopoulos DG, Larroque M, Larroque C, Basbous J, Kossida S, Ribeyre C, Constantinou A.

Life Sci Alliance. 2018 Jun 21;1(3):e201800096. doi: 10.26508/lsa.201800096. eCollection 2018 Jun.

3.

RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma.

Viziteu E, Klein B, Basbous J, Lin YL, Hirtz C, Gourzones C, Tiers L, Bruyer A, Vincent L, Grandmougin C, Seckinger A, Goldschmidt H, Constantinou A, Pasero P, Hose D, Moreaux J.

Leukemia. 2017 Oct;31(10):2104-2113. doi: 10.1038/leu.2017.54. Epub 2017 Feb 10.

4.

Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing.

Laguette N, Brégnard C, Hue P, Basbous J, Yatim A, Larroque M, Kirchhoff F, Constantinou A, Sobhian B, Benkirane M.

Cell. 2014 Jan 16;156(1-2):134-45. doi: 10.1016/j.cell.2013.12.011. Epub 2014 Jan 9.

5.

DNA structure-specific priming of ATR activation by DNA-PKcs.

Vidal-Eychenié S, Décaillet C, Basbous J, Constantinou A.

J Cell Biol. 2013 Aug 5;202(3):421-9. doi: 10.1083/jcb.201304139. Epub 2013 Jul 29.

6.

Induction of ASAP (MAP9) contributes to p53 stabilization in response to DNA damage.

Basbous J, Knani D, Bonneaud N, Giorgi D, Brondello JM, Rouquier S.

Cell Cycle. 2012 Jun 15;11(12):2380-90. doi: 10.4161/cc.20858. Epub 2012 Jun 15.

PMID:
22672907
7.

Heterodimerization with Fra-1 cooperates with the ERK pathway to stabilize c-Jun in response to the RAS oncoprotein.

Talotta F, Mega T, Bossis G, Casalino L, Basbous J, Jariel-Encontre I, Piechaczyk M, Verde P.

Oncogene. 2010 Aug 19;29(33):4732-40. doi: 10.1038/onc.2010.211. Epub 2010 Jun 14.

PMID:
20543861
8.

Fos family protein degradation by the proteasome.

Gomard T, Jariel-Encontre I, Basbous J, Bossis G, Moquet-Torcy G, Piechaczyk M.

Biochem Soc Trans. 2008 Oct;36(Pt 5):858-63. doi: 10.1042/BST0360858. Erratum in: Biochem Soc Trans. 2013 Dec;41(6):1773. Mocquet-Torcy, Gabriel [corrected to Moquet-Torcy, Gabriel].

PMID:
18793151
9.

ASAP is a novel substrate of the oncogenic mitotic kinase Aurora-A: phosphorylation on Ser625 is essential to spindle formation and mitosis.

Venoux M, Basbous J, Berthenet C, Prigent C, Fernandez A, Lamb NJ, Rouquier S.

Hum Mol Genet. 2008 Jan 15;17(2):215-24. Epub 2007 Oct 9.

PMID:
17925329
10.

Ubiquitin-independent- versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: is there a unique answer?

Basbous J, Jariel-Encontre I, Gomard T, Bossis G, Piechaczyk M.

Biochimie. 2008 Feb;90(2):296-305. Epub 2007 Jul 31. Review.

PMID:
17825471
11.

Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.

Basbous J, Chalbos D, Hipskind R, Jariel-Encontre I, Piechaczyk M.

Mol Cell Biol. 2007 Jun;27(11):3936-50. Epub 2007 Mar 19.

12.

The HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies.

Hivin P, Basbous J, Raymond F, Henaff D, Arpin-André C, Robert-Hebmann V, Barbeau B, Mesnard JM.

Retrovirology. 2007 Feb 16;4:14.

13.

Nuclear localization of HTLV-I bZIP factor (HBZ) is mediated by three distinct motifs.

Hivin P, Frédéric M, Arpin-André C, Basbous J, Gay B, Thébault S, Mesnard JM.

J Cell Sci. 2005 Apr 1;118(Pt 7):1355-62. Epub 2005 Mar 8.

14.

HBZ interacts with JunD and stimulates its transcriptional activity.

Thébault S, Basbous J, Hivin P, Devaux C, Mesnard JM.

FEBS Lett. 2004 Mar 26;562(1-3):165-70.

15.

The central region of human T-cell leukemia virus type 1 Tax protein contains distinct domains involved in subunit dimerization.

Basbous J, Bazarbachi A, Granier C, Devaux C, Mesnard JM.

J Virol. 2003 Dec;77(24):13028-35.

16.

The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity.

Basbous J, Arpin C, Gaudray G, Piechaczyk M, Devaux C, Mesnard JM.

J Biol Chem. 2003 Oct 31;278(44):43620-7. Epub 2003 Aug 22.

17.
18.

Human T-cell lymphotropic virus type 1-transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells.

El-Sabban ME, Merhi RA, Haidar HA, Arnulf B, Khoury H, Basbous J, Nijmeh J, de Thé H, Hermine O, Bazarbachi A.

Blood. 2002 May 1;99(9):3383-9.

19.

The cAMP response element binding protein-2 (CREB-2) can interact with the C/EBP-homologous protein (CHOP).

Gachon F, Gaudray G, Thébault S, Basbous J, Koffi JA, Devaux C, Mesnard J.

FEBS Lett. 2001 Jul 27;502(1-2):57-62.

20.

Sequence requirement for the nucleolar localization of human I-mfa domain-containing protein (HIC p40).

Thébault S, Basbous J, Gay B, Devaux C, Mesnard JM.

Eur J Cell Biol. 2000 Nov;79(11):834-8.

PMID:
11139147
21.

[Letter: Thromboembolic disease. Diagnostic value of laboratory tests].

Levy G, Basbous J, Rossi D, Rossi F, François G.

Nouv Presse Med. 1974 Sep 21;3(31):1957. French. No abstract available.

PMID:
4444942

Supplemental Content

Loading ...
Support Center